iridium has been researched along with Arteriosclerosis, Coronary in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dauler, M; Haldis, TA; Maehara, A; Mehran, R; Myers, P; Peng, Y; Popma Almonacid, A; Price, MJ; Shlofmitz, RA; Spriggs, DJ | 1 |
Colombo, A; Di Mario, C; Grube, E; Liistro, F; Montorfano, M; Sgura, FA | 1 |
2 trial(s) available for iridium and Arteriosclerosis, Coronary
Article | Year |
---|---|
Safety and efficacy of the next generation Resolute Onyx zotarolimus-eluting stent: Primary outcome of the RESOLUTE ONYX core trial.
Topics: Aged; Angina, Stable; Cardiovascular Agents; Chromium Alloys; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Iridium; Male; Middle Aged; Percutaneous Coronary Intervention; Platinum; Prospective Studies; Prosthesis Design; Risk Factors; Sirolimus; Time Factors; Treatment Outcome; Ultrasonography, Interventional; United States | 2018 |
The lunar stent characteristics and clinical results.
Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Coated Materials, Biocompatible; Coronary Artery Bypass; Coronary Artery Disease; Coronary Restenosis; Equipment Design; Female; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Iridium; Male; Middle Aged; Prospective Studies; Radiography; Stents | 2002 |